MedPath

平光制药股份有限公司

Ownership
-
Established
2001-11-30
Employees
-
Market Cap
-
Website
http://www.pgzyjt.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

98

NMPA:98

Drug Approvals

Isosorbide Dinitrate Injection

Product Name
硝酸异山梨酯注射液
Approval Number
国药准字H20254468
Approval Date
Jun 10, 2025
NMPA

Pentoxifylline Injection

Product Name
己酮可可碱注射液
Approval Number
国药准字H20244767
Approval Date
Aug 27, 2024
NMPA

Levamlodipine Besilate Tablets

Product Name
苯磺酸左氨氯地平片
Approval Number
国药准字H20243654
Approval Date
Apr 30, 2024
NMPA

Levamlodipine Besilate Tablets

Product Name
苯磺酸左氨氯地平片
Approval Number
国药准字H20243655
Approval Date
Apr 30, 2024
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20234111
Approval Date
Sep 5, 2023
NMPA

Simvastatin Tablets

Product Name
辛伐他汀片
Approval Number
国药准字H20123363
Approval Date
Aug 18, 2022
NMPA

Actarit Tablets

Product Name
阿克他利片
Approval Number
国药准字H20173029
Approval Date
Nov 19, 2021
NMPA

泌感颗粒

Approval Number
国药准字Z20163087
Approval Date
Jun 29, 2021
NMPA

Omeprazole sodium for injection

Product Name
注射用奥美拉唑钠
Approval Number
国药准字H20067752
Approval Date
May 17, 2021
NMPA

Theophylline Sodium Glycinate Sustained Release Tablets

Product Name
甘氨酸茶碱钠缓释片
Approval Number
国药准字H20110102
Approval Date
Mar 16, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.